Trivobiwin 2mg/500mg/0.2mg Tablet
Marketer
Ranmarc Labs
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Trivobiwin 2mg/500mg/0.2mg Tablet
DiabetaComb 2mg/500mg/0.2mg tablets are classified as anti-diabetic medications. This combination therapy treats type 2 diabetes in adults, effectively managing blood glucose levels. DiabetaComb should be taken with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintaining regular meals and carrying a fast-acting glucose source (e.g., sugary snacks, juice) is vital. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before use. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Trivobiwin 2mg/500mg/0.2mg Tablet
The provided text is "undefined," which has no meaning and therefore cannot be rephrased.
Uses of Trivobiwin 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Trivobiwin 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Trivobiwin 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Trivobiwin 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Trivobiwin 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Trivobiwin 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
How Trivobiwin 2mg/500mg/0.2mg Tablet works:
Each Trivobiwin 2mg/500mg/0.2mg tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Trivobiwin 2mg/500mg/0.2mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Trivobiwin 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Trivobiwin 2mg/500mg/0.2mg Tablets. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Trivobiwin 2mg/500mg/0.2mg Tablets due to potential safety concerns. A physician's consultation is advised. Moreover, its use is discouraged for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Trivobiwin 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically recommended for individuals with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Trivobiwin 2mg/500mg/0.2mg Tablet :
Should you forget to take your Trivobiwin 2mg/500mg/0.2mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trivobiwin 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently